Clinical

Dataset Information

0

An observational study of intestinal CRE screening in patients with hematologic malignancies with high risk factors for treatment decisions

ABSTRACT: Interventions: No Group:No intervention Primary outcome(s): CRE screening results Study Design: Sequential

DISEASE(S): Hematologic Malignancy

PROVIDER: 2699279 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignancies.
| S-EPMC9297930 | biostudies-literature
Unknown Paracetamol Intake and Hematologic Malignancies: A Meta-Analysis of Observational Studies.
| S-EPMC8198062 | biostudies-literature
Unknown Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
| S-EPMC2573122 | biostudies-literature
Unknown Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
| S-EPMC6329612 | biostudies-literature
Unknown Neoantigens in Hematologic Malignancies.
| S-EPMC7033457 | biostudies-literature
Unknown Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.
| S-EPMC6334751 | biostudies-literature
Unknown Novel immunotherapies for hematologic malignancies.
| S-EPMC4277117 | biostudies-literature
Unknown BH3 Mimetics in Hematologic Malignancies.
| S-EPMC8466478 | biostudies-literature
Unknown Utility of mTOR inhibition in hematologic malignancies.
| S-EPMC3228224 | biostudies-other
Unknown Targeting oncogenic Ras signaling in hematologic malignancies.
| S-EPMC3482854 | biostudies-other